Literature DB >> 54567

Familial male breast cancer.

R B Everson, F P Li, J F Fraumeni, J Fishman, R E Wilson, D Stout, H J Norris.   

Abstract

Infiltrating ductal carcinoma of the breast occurred in a total of six men from two families. In one family specimens from three men who had prophylactic mastectomies revealed focal intraductal hyperplasia, suggesting a familial tendency toward proliferation of mammary-duct epithelium. In the other family, benign and malignant breast lesions also developed in several women. Preliminary data suggest elevated urinary oestrogen excretion in three men from these families, implicating a defect in oestrogen production or metabolism in the pathogenesis of male breast neoplasms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54567     DOI: 10.1016/s0140-6736(76)92907-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

2.  Mammary malignancy in the male.

Authors:  L L Alexander; D L Benninghoff; M R Camiel; A Medina
Journal:  J Natl Med Assoc       Date:  1978-11       Impact factor: 1.798

3.  Carcinoma of the male breast and oestrogen metabolism.

Authors: 
Journal:  Br Med J       Date:  1978-06-24

4.  Strictly defined familial male breast cancer.

Authors:  Uwe Güth; Dieter Müller; Dorothy Jane Huang; Ellen Obermann; Hansjakob Müller
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

5.  Current management of male breast cancer. A review of 104 cases.

Authors:  P I Borgen; G Y Wong; V Vlamis; C Potter; B Hoffmann; D W Kinne; M P Osborne; W M McKinnon
Journal:  Ann Surg       Date:  1992-05       Impact factor: 12.969

Review 6.  Male breast cancer: is the scenario changing.

Authors:  Kaiyumars B Contractor; Kanchan Kaur; Gabriel S Rodrigues; Dhananjay M Kulkarni; Hemant Singhal
Journal:  World J Surg Oncol       Date:  2008-06-16       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.